Kymera Therapeutics, Inc.

Ownership Transactions Reported by 22 Insiders

Symbol
KYMR on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
500 North Beacon Street, 4 Th Floor, Watertown, MA

Insiders trading volume in the past year

Kymera Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Baker Bros. Advisors Lp Director $648M +$106M +19.5% Aug 20, 2024
Atlas Venture Fund X, L.P. 10%+ Owner $236M -$14.9M -5.95% Mar 11, 2024
Atlas Venture Associates X, L.P. 10%+ Owner $173M Aug 11, 2021
Bruce Booth Director $28.4M -$38.3M -57.5% Jul 9, 2024
Nello Mainolfi Chief Executive Officer, Director $22.7M Jul 1, 2024
Bvf Partners L P/Il Director, Other* $20.1M +$39.3M Aug 20, 2024
Bruce N. Jacobs Chief Financial Officer $5.9M -$165K -2.72% Jun 27, 2024
Jared Gollob Chief Medical Officer $4.4M -$3.6M -45% Jul 15, 2024
Ellen Chiniara Chief Legal Officer $2.42M -$74.4K -2.98% Mar 1, 2024
Jeremy G. Chadwick Chief Operating Officer $1.55M -$90.1K -5.51% May 23, 2024
Elaine Caughey Chief Business Officer $570K Mar 1, 2023
Jeffrey W. Albers Director $0 -$741K -100% Aug 26, 2024
Joanna Horobin Director $0 -$280K -100% Jun 7, 2024
Pamela Esposito Director $0 -$774K -100% Dec 2, 2024
Richard Chesworth Chief Scientific Officer Aug 27, 2021
Steven Edward Hall Director Jun 16, 2021
Victor Sandor Director Jun 18, 2024
Gorjan Hrustanovic Director Jun 18, 2024
Donald William Nicholson Director Jun 15, 2022
Elena Ridloff Director Jun 18, 2024
Leigh Morgan Director Jun 18, 2024
John Maraganore Director Jun 18, 2024

Recent Insider Transactions by Companies or Individuals for Kymera Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.